Clinical trial
A Multicenter, Multi-National, Open-Label, Single Group, Single and Multiple Dose Study of Foscan-Mediated Photodynamic Therapy (PDT) for the Palliative Treatment of Recurrent, Refractory or Second Primary Squamous Cell Carcinomas of the Head and Neck in Patients Considered to be Incurable With Surgery or Radiotherapy
NCT00003856 is registered in ClinicalTrials.gov with Quintiles, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Multi-National, Open-Label, Single Group, Single and Multiple Dose Study of Foscan-Mediated Photodynamic Therapy (PDT) for the Palliative Treatment of Recurrent, Refractory or Second Primary Squamous Cell Carcinomas of the Head and Neck in Patients Considered to be Incurable With Surgery or Radiotherapy
- Lead sponsor
- Quintiles, Inc.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 1998
- Completion date
- Not reported
- Enrollment
- 75 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer